Firmaet fremlagde derfor oplysninger om de to stoffer fra tidligere undersøgelser og fra den videnskabelige litteratur, foruden nye undersøgelser, hvor de to stoffer er anvendt i kombination.
Because amlodipine and valsartan have been used for many years, the company presented information on the two substances from earlier studies and the scientific literature, as well as new studies that used a combination of the two active substances.